Literature DB >> 1436669

Quantification of D-aspartate in normal and Alzheimer brains.

G H Fisher1, A D'Aniello, A Vetere, G P Cusano, M Chávez, L Petrucelli.   

Abstract

Using a new procedure to hydrolyze proteins without provoking racemization of the amino acids and using enzymatic methods to determine D- and L-aspartate (Asp), we have quantified the content of protein-bound D-aspartate (both D-aspartic acid and D-asparagine) of human brain white and gray matter proteins from normal and Alzheimer subjects. The D-enantiomer is present in brain proteins at mean concentrations between 0.48 and 0.90 mumol/g of wet tissue, corresponding to concentrations 34-82 times lower than that of L-aspartate. The highest levels of D-aspartate were found in Alzheimer gray matter (0.60-0.90, mean 0.69 mumol/g of wet tissue). When expressed as the percentage of total (i.e. D- plus L-) aspartate, %D = [D/(D + L)] x 100, the Alzheimer brains show a significantly higher content of D-aspartate in both gray matter (2.08%) and white matter (1.80%) than in the corresponding tissues of normal brains (1.65% in gray, 1.58% in white).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1436669     DOI: 10.1016/0304-3940(92)90268-c

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  D-Aspartyl residue in a peptide can be liberated and metabolized by pig kidney enzymes.

Authors:  Y Kera; K Funabashi; T Matsumoto; T Watanabe; H Nagasaki; R Yamada
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

2.  D-β-aspartyl residue exhibiting uncommon high resistance to spontaneous peptide bond cleavage.

Authors:  Kenzo Aki; Emiko Okamura
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

Review 3.  d-Amino Acids and pLG72 in Alzheimer's Disease and Schizophrenia.

Authors:  Yu-Jung Cheng; Chieh-Hsin Lin; Hsien-Yuan Lane
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

4.  Kinetics of isomerization and inversion of aspartate 58 of αA-crystallin peptide mimics under physiological conditions.

Authors:  Kenzo Aki; Norihiko Fujii; Noriko Fujii
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.